98 related articles for article (PubMed ID: 3090394)
1. Chronic treatment with bromocriptine induces behavioral supersensitivity in rats.
Hassan MN; Higgins D; Traub M; Fahn S
Life Sci; 1986 Aug; 39(6):513-8. PubMed ID: 3090394
[TBL] [Abstract][Full Text] [Related]
2. Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats.
Kenny AM; Schneider MB; Baden DR; Pfeiffer RF; Murrin LC
Neurology; 1986 Mar; 36(3):400-4. PubMed ID: 3081831
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
[TBL] [Abstract][Full Text] [Related]
4. Enhanced stereotypic behavior by chronic treatment with bromocriptine accompanies increase of D-1 receptor binding.
Le WD; Zhou XD; Jin GZ
Life Sci; 1988; 42(19):1841-5. PubMed ID: 2966885
[TBL] [Abstract][Full Text] [Related]
5. The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.
Traub M; Wagner HR; Hassan M; Jackson-Lewis V; Fahn S
Eur J Pharmacol; 1985 Nov; 118(1-2):147-54. PubMed ID: 3936723
[TBL] [Abstract][Full Text] [Related]
6. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
[TBL] [Abstract][Full Text] [Related]
7. Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism.
Nausieda PA; Weiner WJ; Kanapa DJ; Klawans HL
Neurology; 1978 Nov; 28(11):1183-8. PubMed ID: 568738
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats.
Protais P; Dubuc I; Costentin J
Eur J Pharmacol; 1983 Oct; 94(3-4):271-80. PubMed ID: 6140175
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
10. Direct dopamine agonist-like activity conditioned to cocaine.
Silverman PB
Pharmacol Biochem Behav; 1990 Oct; 37(2):231-4. PubMed ID: 2127852
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of apomorphine from bromocriptine, piribidel and TRH by chronic administration in rats.
Porreca F; Cowan A; Tallarida RJ
Psychopharmacology (Berl); 1982; 76(1):70-4. PubMed ID: 6805012
[No Abstract] [Full Text] [Related]
12. Behavioral evidence for supersensitivity after chronic bromocriptine administration.
Smith RC; Strong JR; Hicks PB; Samorajski T
Psychopharmacology (Berl); 1979 Feb; 60(3):241-6. PubMed ID: 108701
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide.
Crider AM; Hemdi TF; Hassan MN; Fahn S
J Pharm Sci; 1984 Nov; 73(11):1585-7. PubMed ID: 6549185
[TBL] [Abstract][Full Text] [Related]
14. Behavioral quantification of striatal dopaminergic supersensitivity after bilateral 6-hydroxydopamine lesions in the mouse.
Mandel RJ; Wilcox RE; Randall PK
Pharmacol Biochem Behav; 1992 Feb; 41(2):343-7. PubMed ID: 1574523
[TBL] [Abstract][Full Text] [Related]
15. Evidence for heterogeneous rotational responsiveness to apomorphine, 3-PPP and SKF 38393 in 6-hydroxydopamine-denervated rats.
Fenton HM; Leszczak E; Gerhardt S; Liebman JM
Eur J Pharmacol; 1984 Nov; 106(2):363-72. PubMed ID: 6442233
[TBL] [Abstract][Full Text] [Related]
16. Behavioral changes in 6-hydroxydopamine-treated rotation rats after delivery of various neuromodifying agents by means of a stereotactically implanted pellet to the brain.
Yoshida M; Torigoe R; Ohtsuru K; Kuramoto S
Stereotact Funct Neurosurg; 1990; 54-55():342-6. PubMed ID: 2127860
[TBL] [Abstract][Full Text] [Related]
17. Ethanol induces rotational behavior in 6-hydroxydopamine lesioned mice.
Silverman PB
Life Sci; 1987 Mar; 40(10):967-71. PubMed ID: 3102871
[TBL] [Abstract][Full Text] [Related]
18. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
[TBL] [Abstract][Full Text] [Related]
19. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
20. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
